Should doctors advocate snus and other nicotine replacements? Yes
Author:
Abstract
Safer choicesBy far the safest alternative is the current range of nicotine replacement products. All reduce the symptoms of withdrawal from smoking and therefore, although marketed and licensed primarily as cessation aids, are also logical long term substitutes for cigarettes. However, because of their low dose and delivery rate they are not highly effective; smokers find them helpful but not satisfying as a cigarette substitute. So it would help if medicinal nicotine products could be developed to mimic the cigarette more closely—delivering high doses, quickly, on demand.Another, and more controversial, alternative source of nicotine is smokeless tobacco or snuff—tobacco for oral or nasal use. Smokeless tobacco products are all considerably more hazardous than nicotine replacement therapy and some especially so. The Swedish moist tobacco products (known as snus) are among the less hazardous and cause pancreatic cancer, probably cardiovascular disease, and various other health problems.8 9 10 11 12 However, because these risks are all lower for snus than for smoking, and because snus use does not cause lung cancer or chronic obstructive pulmonary disease, snus use is substantially less hazardous than smoking. Recent data from Sweden, where snus has been available for years, indicate that habitual smokers and young people experimenting with tobacco products have substituted snus for cigarettes, resulting in low levels of smoking.13 14 This suggests that smokeless tobacco is an acceptable smoking substitute for some smokers and therefore snus may be effective in this role in other populations. Although nicotine replacement therapy is not licensed for use as a long term substitute for smoking, in practice it is common sense for health professionals dealing with smokers who are unable to quit smoking to encourage use of medicinal nicotine products as a substitute for smoking, and prescribe them if necessary. They should strongly advise smokers that the best option would be to quit all nicotine use, and do all they can to support this by encouraging uptake of behavioural therapy supported by nicotine replacement therapy, bupropion, or varenicline in accordance with established clinical guidelines. However, for those who try repeatedly and fail, or for those who are not ready to stop using nicotine, switching to a medicinal nicotine product is the logical next best option. Doctors should encourage this.Using smokeless tobacco is another matter. In the UK, the only legally available smokeless products are the more hazardous ones because the 1992 Tobacco for Oral Use (Safety) Regulations prohibit the supply of oral tobacco products that are not intended to be smoked or chewed. Snus is intended to be sucked, so it is illegal for a doctor or anyone else to supply it, although mail order purchase for personal use from a supplier in Sweden is within the law. In my view, as a measure of last resort in smokers who have tried all other cessation and substitution options, doctors would be justified in suggesting an individual trial of snus. Whether this approach will prove effective remains to be seen and desperately needs to be tested in clinical trials. However, while the alternative is equivalent to a form of Russian roulette in which every other chamber of the revolver holds a bullet, pursuing a less hazardous alternative—even this one—surely makes sense.Keywords
This publication has 8 references indexed in Scilit:
- Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort studyThe Lancet, 2007
- Social inequalities in male mortality, and in male mortality from smoking: indirect estimation from national death rates in England and Wales, Poland, and North AmericaThe Lancet, 2006
- The Decline of Smoking in Northern SwedenScandinavian Journal of Public Health, 2005
- Mortality in relation to smoking: 50 years' observations on male British doctorsBMJ, 2004
- Is smokeless tobacco a risk factor for coronary heart disease? A systematic review of epidemiological studiesEuropean Journal of Preventive Cardiology, 2004
- Health effects associated with smokeless tobacco: a systematic reviewThorax, 2003
- Impact of smokeless tobacco use on smoking in northern SwedenJournal of Internal Medicine, 2002
- Nicotine Medications for Smoking CessationNew England Journal of Medicine, 1995